2016 Publications

NoTitleAuthorsYear
1Age- and Sex-Specific Social Contact Patterns and Incidence of Mycobacterium tuberculosis InfectionDodd PJ, Looker C, Plumb ID, Bond V, Schaap A, Shanaube K, Muyoyeta M, Vynnycky E, Godfrey-Faussett P, Corbett EL, Beyers N, Ayles H, White RG.2016
2Absence of Active Hepatitis C Virus Infection in Human Immunodeficiency Virus Clinics in Zambia and MozambiqueWandeler G, Mulenga L, Hobbins M, Joao C, Sinkala E, Hector J, Aly M, Chi BH, Egger M, Vinikoor MJ.2016
3Association between hepatitis B infection and elevated liver stiffness among HIV-infected adults in Lusaka, ZambiaVinikoor MJ, Mulenga L, Siyunda A, Musukuma K, Chilengi R, Moore CB, Chi BH, Davies MA, Egger M, Wandeler G.2016
4Association of Maternal Immunity With Rotavirus Vaccine Immunogenicity in Zambian InfantsRoma Chilengi, Michelo Simuyandi, Lauren Beach, Katayi Mwila, Sylvia Becker-Dreps, Devy M. Emperador, Daniel E. Velasquez, Samuel Bosomprah, Baoming Jiang2016
5Chest radiograph reading and recording system: evaluation in frontline clinicians in ZambiaHenostroza G, Harris JB, Kancheya N, Nhandu V, Besa S, Musopole R, Krüüner A, Chileshe C, Dunn IJ, Reid SE.2016
6Comparison of indoor contact time data in Zambia and Western Cape, South Africa suggests targeting of interventions to reduce Mycobacterium tuberculosis transmission should be informed by local data.McCreesh N, Looker C, Dodd PJ, Plumb ID, Shanaube K, Muyoyeta M, Godfrey-Faussett P, Corbett EL, Ayles H, White RG.2016
7Contraceptive use among HIV-infected women and men receiving antiretroviral therapy in Lusaka, Zambia: a cross-sectional surveyHancock NL, Chibwesha CJ, Bosomprah S, Newman J, Mubiana-Mbewe M, Sitali ES, Bolton-Moore C, Mbwili-Muleya C, Chi BH.2016
8Contribution of maternal immunity to decreased rotavirus vaccine performance in low and middle income countriesMwila K, Chilengi R, Simuyandi M, Permar SR, Becker-Dreps S.2016
9Costs of introducing pneumococcal, rotavirus and a second dose of measles vaccine into the Zambian immunisation programme: Are expansions sustainable?Griffiths UK, Bozzani FM, Chansa C, Kinghorn A, Kalesha-Masumbu P, Rudd CChilengi R, Brenzel L, Schutte C.2016
10Coverage of clinic-based TB screening in South Africa may be low in key risk groupsMcCreesh N, Faghmous I, Looker C, Dodd PJ, Plumb ID, Shanaube K, Muyoyeta M, Godfrey-Faussett P, Ayles H, White RG.2016
11Coverage of clinic-based TB screening in South Africa may be low in key risk groupsMcCreesh N, Faghmous I, Looker C, Dodd PJ, Plumb ID, Shanaube K, Muyoyeta M, Godfrey-Faussett P, Ayles H, White RG2016
12Diabetes mellitus in Zambia and the Western Cape province of South Africa: Prevalence, risk factors, diagnosis and managementBailey SL, Ayles H, Beyers N, Godfrey-Faussett P, Muyoyeta M, du Toit E, Yudkin DS, Floyd S. 2016
13Exploring the drivers of health and healthcare access in Zambian prisons: a health systems approachTopp SM, Moonga CN, Luo N, Kaingu M, Chileshe C, Magwende G, Heymann SJ, Henostroza G2016
14Feasibility and Effectiveness of a Peer Referral Incentive Intervention to Promote Male Circumcision Uptake in ZambiaZanolini A, Bolton C, Lyabola LL, Phiri G, Samona A, Kaonga A, Thirumurthy H.2016
15Findings from a comprehensive diarrhoea prevention and treatment programme in Lusaka, ZambiaBosomprah S., Beach LB, Beres LK, Newman J, Kapasa K, Rudd C, Njobvu L, Guffey B, Hubbard S, Foo K, Bolton-Moore C, Chilengi R.2016
16Has the phasing out of stavudine in accordance with changes in WHO guidelines led to a decrease in single-drug substitutions in first-line antiretroviral therapy for HIV in sub-Saharan Africa?Brennan AT, Davies MA, Bor J, Wandeler G, Stinson K, Wood R, Prozesky H, Tanser F, Fatti G, Boulle A, Sikazwe I, Wool-Kaloustian K, Yiannoutsos C, Leroy V, de Rekeneire N, Fox MP.2016
17Health and healthcare access among Zambia’s female prisoners: a health systems analysisStephanie M. Topp, Clement N. Moonga, Constance Mudenda, Nkandu Luo, Michael Kaingu, Chisela Chileshe, George Magwende, Jody S. Heymann and German Henostroza2016
18Health Promotion Through Existing Community Structures: A Case of Churches Roles in Promoting Rotavirus Vaccination in Rural Zambia.
Wesevich A, Chipungu J, Mwale M, Bosomprah S, Chilengi R.
 
2016
19Hepatitis B Infection, Viral Load and Resistance in HIV-Infected Patients in Mozambique and ZambiaWandeler G, Musukuma K, Zürcher S, Vinikoor MJ, Llenas-García J, Aly MM, Mulenga L, Chi BH, Ehmer J, Hobbins MA, Bolton-Moore C, Hoffmann CJ, Egger M: IeDEA-Southern Africa.2016
20High prevalence of tuberculosis in newly enrolled HIV patients in Zambia: need for enhanced screening approachHenostroza G, Harris JB, Chitambi R, Siyambango M, Turnbull ER, Maggard KRKrüüner A, Kapata N, Reid SE.2016
21HIV and new onset seizures: slipping through the cracks in HIV care and treatment.Sikazwe I, Elafros MA, Bositis CM, Siddiqi OK, Koralnik IJ, Kalungwana L, Theodore WH, Okulicz JF, Potchen MJ, Birbeck GL.2016
22Impact of targeted counseling on reported vaginal hygiene practices and bacterial vaginosis: the HIV Prevention Trials Network 035 studyKasaro MP, Husnik MJ, Chi BH, Reid C, Magure T, Makanani B, Tembo T, Ramjee G, Maslankowski L, Rabe L, Brad Guffey M.2016
23Liver Fibrosis in Treatment-naïve HIV-infected and HIV/HBV-coinfected Patients: Zambia and Switzerland ComparedWandeler G, Mulenga L, Vinikoor MJ, Kovari H, Battegay M, Calmy A, Cavassini M, Bernasconi E, Schmid P, Bolton-Moore C, Sinkala E, Chi BH, Egger M, Rauch A; for IeDEA-Southern Africa, the Swiss HIV Cohort Study.2016
24Long-term follow-up of HIV seroconverters in microbicide trials – rationale, study design, and challenges in MTN-015Riddler SA, Husnik M, Gorbach PM, Levy L, Parikh U, Livant E, Pather A, Makanani B, Muhlanga F, Kasaro M, Martinson F, Elharrar V, Balkus JE; MTN-015 Protocol Team for the Microbicide Trials Network.2016
25Mapping the Zambian prison health system: An analysis of key structural determinantsTopp SM, Moonga CN, Luo N, Kaingu M, Chileshe C, Magwende G, Henostroza G.2016
26Multiple behaviour change intervention for diarrhoea control in Lusaka, Zambia: a cluster randomised trialKatie Greenland, Jenala Chipungu, Val Curtis, Wolf-Peter Schmidt, Zumbe Siwale, Mweetwa Mudenda, Joyce Chilekwa, James J Lewis, Roma Chilengi2016
27Perceptions and Experiences of Integrated Service Delivery Among Women Living with HIV Attending Reproductive Health Services in Kenya: A Mixed Methods StudyColombini M, Mayhew SH, Mutemwa R, Kivunaga J, Ndwiga C; Integra Team.2016
28The association of hyperglycaemia with prevalent tuberculosis: a population-based cross-sectional studyBailey SL, Ayles H, Beyers N, Godfrey-Faussett P, Muyoyeta M, du Toit E, Yudkin JS, Floyd S.2016
29The Lancet: HIV and Tuberculosis in Prisons in sub-Saharan AfricaLilanganee Telisinghe, Salome Charalambous, Stephanie M. Topp, Micheal E. Herce, Christopher J. Hoffman, Peter Barron, Erik J. Schouten, Andreas Jahn, Rony Zachariah, Anthony D. Harries, Chris Beyrer, Joseph J. Amon2016
30The Lancet: Prevention of HIV, Hepatitis B Virus, Hepatitis C Virus, and Tuberculosis in PrisonersAdeeba Kamarulzaman, Stewart E. Reid, Amee Schwitters, Nabila El-Bassel, Kate Dolan, Babak Moazen, Andrea L. Wirtz, Annette Verster, Frederick L. Altice2016
31Theory-based formative research on oral rehydration salts and zinc use in Lusaka, ZambiaGreenland K, Chipungu J, Chilengi R, Curtis V.2016
32Understanding Sustained Retention in HIV/AIDS Care and Treatment: a Synthetic ReviewRoy M, Czaicki N, Holmes C, Chavan S, Tsitsi A, Odeny T, Sikazwe I, Padian N, Geng E.2016